HANGZHOU TIGERMED revenue breakdown overview

HANGZHOU TIGERMED revenue for the last year amounted to 7.38 B CNY, the most of which — 4.17 B CNY — came from its highest performing source at the moment, Clinical Trial Technical Services, the year earlier bringing 4.13 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought HANGZHOU TIGERMED 4.23 B CNY, and the year before that — 3.60 B CNY.